Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 2004; Volume 66,Issue 2

Perspective

  • You have access
    Ca2+ Regulation of Inositol 1,4,5-trisphosphate Receptors: Can Ca2+ Function without Calmodulin?
    Ana M. Rossi and Colin W. Taylor
    Molecular Pharmacology August 2004, 66 (2) 199-203; DOI: https://doi.org/10.1124/mol.104.002592

Articles

  • You have access
    Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice
    Kunlin Jin, Lin Xie, Sun Hee Kim, Sophie Parmentier-Batteur, Yunjuan Sun, Xiao Ou Mao, Jocelyn Childs and David A. Greenberg
    Molecular Pharmacology August 2004, 66 (2) 204-208; DOI: https://doi.org/10.1124/mol.66.2.204
  • You have access
    Ligand-Binding Residues Integrate Affinity and Efficacy in the NMDA Receptor
    Trisha L. Kalbaugh, Hendrika M. A. VanDongen and Antonius M. J. VanDongen
    Molecular Pharmacology August 2004, 66 (2) 209-219; DOI: https://doi.org/10.1124/mol.66.2.209
  • You have access
    Reduction of Renal Ischemia-Reperfusion Injury in 5-Lipoxygenase Knockout Mice and by the 5-Lipoxygenase Inhibitor Zileuton
    Nimesh S. A. Patel, Salvatore Cuzzocrea, Prabal K. Chatterjee, Rosanna Di Paola, Lidia Sautebin, Domenico Britti and Christoph Thiemermann
    Molecular Pharmacology August 2004, 66 (2) 220-227; DOI: https://doi.org/10.1124/mol.66.2.220
  • You have access
    High-Affinity Interactions between Human α1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the α1L-Adrenoceptor
    Douglas Ramsay, I. Craig Carr, John Pediani, Juan F. Lopez-Gimenez, Richard Thurlow, Mark Fidock and Graeme Milligan
    Molecular Pharmacology August 2004, 66 (2) 228-239; DOI: https://doi.org/10.1124/mol.66.2.228
  • You have access
    Structural Determinants of HERG Channel Block by Clofilium and Ibutilide
    Matthew Perry, Marcel J. de Groot, Ray Helliwell, Derek Leishman, Martin Tristani-Firouzi, Michael C. Sanguinetti and John Mitcheson
    Molecular Pharmacology August 2004, 66 (2) 240-249; DOI: https://doi.org/10.1124/mol.104.000117
  • You have access
    Identification of a Novel Site within G Protein α Subunits Important for Specificity of Receptor-G Protein Interaction
    Arne Heydorn, Richard J. Ward, Rasmus Jorgensen, Mette M. Rosenkilde, Thomas M. Frimurer, Graeme Milligan and Evi Kostenis
    Molecular Pharmacology August 2004, 66 (2) 250-259; DOI: https://doi.org/10.1124/mol.66.2.250
  • You have access
    Cholinergic Stimulation of Salivary Secretion Studied with M1 and M3 Muscarinic Receptor Single- and Double-Knockout Mice
    Dinesh Gautam, Thomas S. Heard, Yinghong Cui, Georgina Miller, Lanh Bloodworth and Jürgen Wess
    Molecular Pharmacology August 2004, 66 (2) 260-267; DOI: https://doi.org/10.1124/mol.66.2.260
  • You have access
    Strategies for Inhibition of MDR1 Gene Expression
    Dong Xu, Hyunmin Kang, Michael Fisher and R. L. Juliano
    Molecular Pharmacology August 2004, 66 (2) 268-275; DOI: https://doi.org/10.1124/mol.66.2.268
  • You have access
    The N-terminal Ca2+-Independent Calmodulin-Binding Site on the Inositol 1,4,5-trisphosphate Receptor Is Responsible for Calmodulin Inhibition, Even Though This Inhibition Requires Ca2+
    Nael Nadif Kasri, Geert Bultynck, Jeremy Smyth, Karolina Szlufcik, Jan B. Parys, Geert Callewaert, Ludwig Missiaen, Rafael A. Fissore, Katsuhiko Mikoshiba and Humbert de Smedt
    Molecular Pharmacology August 2004, 66 (2) 276-284; DOI: https://doi.org/10.1124/mol.66.2.276
  • You have access
    Synergistic Antitumor Activity of Troxacitabine and Camptothecin in Selected Human Cancer Cell Lines
    Tracy E. Kim, Shin-Young Park, Chih-Hung Hsu, Ginger E. Dutschman and Yung-Chi Cheng
    Molecular Pharmacology August 2004, 66 (2) 285-292; DOI: https://doi.org/10.1124/mol.66.2.285
  • You have access
    Prostaglandin E2 Inhibits the Phospholipase D Pathway Stimulated by Formyl-methionyl-leucyl-phenylalanine in Human Neutrophils. Involvement of EP2 Receptors and Phosphatidylinositol 3-kinase γ
    Chantal Burelout, Nathalie Thibault, Sylvain Levasseur, Sébastien Simard, Paul H. Naccache and Sylvain G. Bourgoin
    Molecular Pharmacology August 2004, 66 (2) 293-301; DOI: https://doi.org/10.1124/mol.66.2.293
  • You have access
    p38 Mitogen-Activated Protein Kinase Mediates Synergistic Induction of Inducible Nitric-Oxide Synthase by Lipopolysaccharide and Interferon-γ through Signal Transducer and Activator of Transcription 1 Ser727 Phosphorylation in Murine Aortic Endothelial Cells
    Hong Huang, Jane L. Rose and Dale G. Hoyt
    Molecular Pharmacology August 2004, 66 (2) 302-311; DOI: https://doi.org/10.1124/mol.66.2.302
  • You have access
    Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers
    Mohammed A. Ayoub, Angélique Levoye, Philippe Delagrange and Ralf Jockers
    Molecular Pharmacology August 2004, 66 (2) 312-321; DOI: https://doi.org/10.1124/mol.104.000398
  • You have access
    Tumor Necrosis Factor-α Differentially Regulates the Expression of Proinflammatory Genes in Human Airway Smooth Muscle Cells by Activation of Interferon-β–Dependent CD38 Pathway
    Omar Tliba, Reynold A. Panettieri, Samira Tliba, Timothy F. Walseth and Yassine Amrani
    Molecular Pharmacology August 2004, 66 (2) 322-329; DOI: https://doi.org/10.1124/mol.104.001040
  • You have access
    Unexpected Mexiletine Responses of a Mutant Cardiac Na+ Channel Implicate the Selectivity Filter as a Structural Determinant of Antiarrhythmic Drug Access
    Koji Sasaki, Naomasa Makita, Akihiko Sunami, Harumizu Sakurada, Nobumasa Shirai, Hisataka Yokoi, Akinori Kimura, Noritsugu Tohse, Masayasu Hiraoka and Akira Kitabatake
    Molecular Pharmacology August 2004, 66 (2) 330-336; DOI: https://doi.org/10.1124/mol.66.2.330
  • You have access
    Interleukin-1β–Induced Mucin Production in Human Airway Epithelium Is Mediated by Cyclooxygenase-2, Prostaglandin E2 Receptors, and Cyclic AMP-Protein Kinase A Signaling
    Thomas Gray, Paul Nettesheim, Charles Loftin, Ja-Seok Koo, James Bonner, Shyamal Peddada and Robert Langenbach
    Molecular Pharmacology August 2004, 66 (2) 337-346; DOI: https://doi.org/10.1124/mol.66.2.337
  • You have access
    Differential Modulation of β2 and β4 Subunits of Human Neuronal Nicotinic Acetylcholine Receptors by Acidification
    Galya Abdrakhmanova, Lars Cleemann, Jon Lindstrom and Martin Morad
    Molecular Pharmacology August 2004, 66 (2) 347-355; DOI: https://doi.org/10.1124/mol.66.2.347
  • You have access
    “Induced-Fit” Mechanism for Catecholamine Binding to the β2-Adrenergic Receptor
    Renata Del Carmine, Paola Molinari, Maria Sbraccia, Caterina Ambrosio and Tommaso Costa
    Molecular Pharmacology August 2004, 66 (2) 356-363; DOI: https://doi.org/10.1124/mol.66.2.356
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 66 (2)
Molecular Pharmacology
Vol. 66, Issue 2
1 Aug 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Perspective
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics